A prospective randomized controlled clinical trial for the efficacy of tanshinone therapy in intrauterine adhesion after transcervical resection of adhesion(TCRA)

A prospective randomized controlled clinical trial for the efficacy of tanshinone therapy in intrauterine adhesions after transcervical resection of adhension (TCRA)

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-17011179

Enrollment

Unknown

Registered

2017-04-18

Start date

2017-06-01

Completion date

Unknown

Last updated

2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

interuterine adhesion

Interventions

Experimental group:Tashinone+Estrogen

Control group:Estrogen

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Aged 20-40 years; (2) No hormone used in the past 3 months; (3) Patients are diagnosised with intrauterine adhesions by Hysteroscopy; (4) Patients have fertility requirements; (5) Patients all are voluntared to participate in the trial.

Exclusion criteria

Exclusion criteria: 1. patient has contraindication to Tashinone; 2. Previous history of Transcervical resection of adhesion; 3. Hormone used in the past one month; 4. Causes of abnormal uterine bleeding included; 5. A history of recent uterine perforation; 6. Long term therapy of anticoagulant drugs;

Design outcomes

Primary

Measure	Time frame
Endometrial thickness;Endometrial blood flow;Incidence of adhesion reformation ;	—

Secondary

Measure	Time frame
Pregnancy outcome;Menstruation;Recovery of impaired endometrium;	—

Countries

China

Contacts

Public ContactZHANG SHU

Department of Gynecology and Obstetrics, Renji Hospital, School of Medicine, Shanghai Jiao Tong University

drzhangshu@126.com+86 15800647126

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026